HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano
Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2PositivemBC22).
